The Japan Times - Ozempic slimming craze sweeps Kosovo despite side effects

EUR -
AED 4.03611
AFN 70.905943
ALL 90.365015
AMD 393.347716
ANG 1.96767
AOA 1008.891074
ARS 1705.944091
AUD 1.634409
AWG 1.978217
AZN 1.863377
BAM 1.955016
BBD 2.212803
BDT 137.225001
BGN 1.949061
BHD 0.414532
BIF 3303.760831
BMD 1.09901
BND 1.415926
BOB 12.815863
BRL 6.350053
BSD 1.098675
BTN 102.63593
BWP 15.378906
BYN 3.297154
BYR 21540.586588
BZD 2.209704
CAD 1.572441
CDF 2521.127509
CHF 0.923701
CLF 0.027762
CLP 1092.624243
CNY 7.326162
CNH 7.328553
COP 3636.644481
CRC 489.401623
CUC 1.09901
CUP 26.368432
CVE 110.222328
CZK 24.363932
DJF 195.650694
DKK 7.474446
DOP 66.533031
DZD 150.66763
EGP 59.036808
ERN 16.485143
ETB 180.325124
FJD 2.525411
FKP 0.831491
GBP 0.832571
GEL 2.847083
GGP 0.831491
GHS 12.892422
GIP 0.831491
GMD 81.327192
GNF 9734.05433
GTQ 8.396749
GYD 229.7506
HKD 8.621867
HNL 29.538027
HRK 7.508395
HTG 143.940344
HUF 366.79498
IDR 20058.297498
ILS 3.576886
IMP 0.831491
INR 102.710297
IQD 1665.617269
IRR 2120048.169816
ISK 136.794166
JEP 0.831491
JMD 174.589231
JOD 0.779232
JPY 175.21014
KES 142.860739
KGS 96.107293
KHR 4482.142394
KMF 492.35665
KPW 989.108952
KRW 1461.435378
KWD 0.34255
KYD 0.915625
KZT 487.790057
LAK 24745.082234
LBP 98389.403917
LKR 365.583475
LRD 184.574344
LSL 18.587535
LTL 3.245089
LVL 0.664779
LYD 7.100122
MAD 10.965605
MDL 20.117395
MGA 4997.951357
MKD 61.561695
MMK 2307.246479
MNT 3963.856267
MOP 8.879562
MRU 44.518954
MUR 52.598085
MVR 16.91855
MWK 1905.119098
MXN 20.276784
MYR 4.504948
MZN 70.224428
NAD 18.587281
NGN 1484.618777
NIO 40.43361
NOK 10.589671
NPR 164.218435
NZD 2.000516
OMR 0.422596
PAB 1.09866
PEN 3.752296
PGK 4.942951
PHP 69.869499
PKR 303.762999
PLN 4.405413
PYG 6845.225309
QAR 4.005149
RON 5.348662
RSD 117.636835
RUB 90.336961
RWF 1626.033494
SAR 4.133269
SBD 8.942686
SCR 15.26766
SDG 661.102559
SEK 11.138577
SGD 1.416871
SHP 0.832079
SLE 25.059896
SLL 23045.684153
SOS 627.845505
SRD 41.144721
STD 22747.278168
STN 24.48985
SVC 9.61306
SYP 14289.322147
SZL 18.585635
THB 37.219081
TJS 10.124296
TMT 3.846533
TND 3.324713
TOP 2.646152
TRY 55.432391
TTD 7.438951
TWD 36.235994
TZS 2912.378494
UAH 49.805285
UGX 4559.027563
USD 1.09901
UYU 44.631909
UZS 13203.707988
VES 1006.145306
VND 28228.609021
VUV 133.051231
WST 3.102812
XAF 655.957
XAG 0.023897
XAU 0.0002891088
XCD 2.970128
XCG 1.980088
XDR 0.777057
XOF 655.957
XPF 119.331742
YER 259.970427
ZAR 18.636619
ZMK 9892.394504
ZMW 22.506877
ZWL 353.880617
SSP 6515.706009
MXV 2.274732
  • RYCEF

    0.1000

    19.81

    +0.5%

  • VOD

    -0.2500

    16.33

    -1.53%

  • CMSC

    -0.2800

    20.12

    -1.39%

  • RBGPF

    -2.0000

    65

    -3.08%

  • RIO

    -0.2500

    94.16

    -0.27%

  • BTI

    -1.2000

    54.85

    -2.19%

  • NGG

    -0.3000

    74.94

    -0.4%

  • GSK

    -0.3500

    49.35

    -0.71%

  • BCE

    -0.4200

    20.14

    -2.09%

  • CMSD

    -0.3400

    19.93

    -1.71%

  • BP

    -0.9100

    43.52

    -2.09%

  • RELX

    0.1700

    33.24

    +0.51%

  • BCC

    -0.6200

    75.97

    -0.82%

  • AZN

    -1.9400

    164.21

    -1.18%

  • JRI

    0.0000

    10.77

    0%

Ozempic slimming craze sweeps Kosovo despite side effects
Ozempic slimming craze sweeps Kosovo despite side effects / Photo: Armend NIMANI - AFP

Ozempic slimming craze sweeps Kosovo despite side effects

Kosovo influencer Tringa Kadriu sees the slimming drug Ozempic as a chance to shed excess pounds -- and she is not the only one in her Balkan nation, where more than half the population is overweight.

Text size:

"I want to lose 15-16 kilos (33-35 pounds) in two months," Kadriu, 29, told AFP, "and then I'll continue with fitness".

Ozempic, approved in the United States to treat diabetes in 2017, has found an international market for people trying to lose weight.

Despite its cost, the drug has soared in popularity in Kosovo, a country of 1.7 million.

While Kosovo authorities have not sanctioned the drug's use for weight loss, they have noted their limited means to confront use of a drug widely available in the country.

Merita Emini-Sadiku, who heads the Kosovo university hospital's endocrinology clinic, said the cost of the drug had soared.

"The monthly dose used to be 75-80 euros ($85-91), while now it is 130-140 euros ($147-159), probably due to high demand," she said.

But she warned that "Ozempic has side effects that people are not aware of".

Ozempic use can potentially cause issues including thyroid cancer, pancreatitis, gastroparesis and bowel obstruction, according to the latest studies.

- 'Constant demand' -

Meant to treat Type 2 diabetes -- of which the WHO says Kosovo has lower than average levels -- the drug regulates blood sugar levels but also helps suppress hunger, leading to a lower calorie intake.

As a result, its potentially cancerous complications have done little to stem the drug's popularity or availability.

"I checked a lot of pharmacies in Kosovo and I noticed that Ozempic is very easy to get," said Kadriu, adding that pharmacists even suggested she gradually increase her dosage.

A worker at a pharmacy in the capital Pristina's downtown, who asked to remain anonymous, said she had trouble recalling when someone last came into her pharmacy to buy Ozempic with a diabetes prescription.

"But we have a constant demand for Ozempic without a prescription. You can guess why," she said.

Given its availability, Emini-Sadiku said authorities should exercise greater control over Ozempic's distribution.

But Bujar Vitija, a journalist specialising in health, said that would be tricky to achieve given Kosovo's poor health record-keeping.

"Unfortunately there is no data," Vitija said.

With 1,500 to 1,600 private pharmacies in Kosovo, the country's 20 pharmaceutical inspectors have their work cut out for them, he added.

- Ozempic 'every day' -

While Kosovo has lower levels of obesity than the European average, more than 57 percent of the population is overweight and 20 percent is clinically obese, according to a 2019 World Health Organization report.

And women, who are more likely to face societal pressure to be thin, were 66 percent more likely to be obese than men, the WHO report found.

But not every Kosovar who has used Ozempic had the best experience with the drug.

"I took Ozempic on the advice of a doctor for two years but it had no effect," said 48-year-old merchant Lulzim Rrahmani, adding that three of his relatives even experienced "a negative effect of the drug".

"It was just a waste of money and time."

Given the risk of side effects, Emini-Sadiku said Ozempic was "by no means to be taken without a doctor's prescription".

Yet Kadriu said she would not be deterred, adding that she saw colleagues taking the drug "every day at work".

"I don't see any symptom that would deter me."

S.Yamada--JT